01:42 PM EDT, 10/04/2024 (MT Newswires) -- Health care stocks eased Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both down 0.1%.

The iShares Biotechnology ETF (IBB) rose 0.4%.

In corporate news, Organon's (OGN) finasteride-containing Propecia product is under review in Europe over the ingredient's link to the risk of suicidal thoughts and behaviors, the European Medicines Agency said. GSK's (GSK) Avodart is also under review by regulators, Reuters reported. Organon shares rose 0.8%, and GSK climbed 0.6%.